These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10856454)

  • 1. Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia models.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    Eur J Pharmacol; 2000 Jun; 398(1):107-12. PubMed ID: 10856454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antiarrhythmic profile of AP-792 assessed in different canine arrhythmia models.
    Takahara A; Hirasawa A; Dohmoto H; Shoji M; Yoshimoto R; Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 2001 Sep; 87(1):21-6. PubMed ID: 11676194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AH-1058: a novel cardioselective Ca2+ channel blocker.
    Takahara A; Sugiyama A; Yoshimoto R; Hashimoto K
    Cardiovasc Drug Rev; 2001; 19(4):279-96. PubMed ID: 11830748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine model.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    Jpn J Pharmacol; 2000 Jun; 83(2):107-12. PubMed ID: 10928322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
    Takahara A; Dohmoto H; Yoshimoto R; Sugiyama A; Hashimoto K
    Eur J Pharmacol; 2001 Feb; 413(1):101-8. PubMed ID: 11173068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of KT-362, a new Na and Ca influx and Ca release inhibitor, on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Mochizuki S; Tomiyama A
    Jpn J Pharmacol; 1989 Dec; 51(4):475-82. PubMed ID: 2559225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of telemetry system to assess the cardiovascular profile of AH-1058, a new cardioselective Ca2+ channel blocker, in conscious dogs.
    Takahara A; Dohmoto H; Yoshimoto R; Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 2001 Mar; 85(3):331-4. PubMed ID: 11325028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new antiarrhythmic drug, SD-3212, on canine ventricular arrhythmia models.
    Hirasawa A; Haruno A; Matsuzaki T; Hashimoto K
    Jpn Heart J; 1992 Nov; 33(6):851-61. PubMed ID: 1299746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models.
    Mitsuhashi H; Akiyama K; Hashimoto K; Sawa Y; Hatori Y
    Jpn J Pharmacol; 1987 Jun; 44(2):155-62. PubMed ID: 3656773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Ca(2+) channel-blocking effects of the cyproheptadine derivative AH-1058 in isolated guinea pig cardiomyocytes.
    Dohmoto H; Takahara A; Uneyama H; Yoshimoto R
    J Pharmacol Sci; 2003 Feb; 91(2):163-6. PubMed ID: 12686762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
    Chen J; Xue Y; Eto K; Ni C; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.
    Takahara A; Uneyama H; Sasaki N; Ueda H; Dohmoto H; Shoji M; Hara Y; Nakaya H; Yoshimoto R
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):625-32. PubMed ID: 10218734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride.
    Alexanian AR; Arutyunian NS; Galoyan AA
    Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):29-39. PubMed ID: 2656435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel antagonistic effects of AH-1058, a novel antiarrhythmic drug, on guinea-pig myocardium.
    Tanaka H; Ichikawa T; Matsui S; Okazaki K; Masumiya H; Kawanishi T; Shigenobu K
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):13-21. PubMed ID: 10604274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles.
    Hashimoto K; Watanabe K; Mitsuhashi H
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):683-9. PubMed ID: 2488108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.